The number of STING-positive cells in the liver tissues of patients with NAFLD increases with inflammation and fibrosis, suggesting that STING influences NAFLD progression and may be a key regulator of inflammation and fibrosis [80]. This evidence concerns the gene STING1 and metabolic dysfunction-associated steatotic liver disease.